Indications for: COMIRNATY

Active immunization to prevent COVID-19 in individuals ≥12yrs of age.

Adults and Children:

<12yrs: not established. Give by IM inj only. ≥12yrs: 0.3mL given as a 2-dose series 3 weeks apart.

COMIRNATY Warnings/Precautions:

Have epinephrine inj available. Increased risks of myocarditis and pericarditis (esp. within 7 days after the second dose); higher risk among males <40yrs of age, and highest among males 12–17yrs of age. Syncope. Immunocompromised. Pregnancy. Nursing mothers.

COMIRNATY Classification:

COVID-19 vaccine.

COMIRNATY Interactions:

Immunosuppressants: may get suboptimal response.

Adverse Reactions:

Inj site reactions (eg, pain, swelling, redness), fatigue, headache, muscle pain, chills, joint pain, fever.

Generic Drug Availability:


How Supplied:

Multiple-dose vials—25, 195 (w. diluent; shipped separately)